scispace - formally typeset
D

Doron Melamed

Researcher at Technion – Israel Institute of Technology

Publications -  49
Citations -  2240

Doron Melamed is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: B cell & Receptor editing. The author has an hindex of 23, co-authored 49 publications receiving 2015 citations. Previous affiliations of Doron Melamed include Rappaport Faculty of Medicine.

Papers
More filters
Journal ArticleDOI

Developmental Regulation of B Lymphocyte Immune Tolerance Compartmentalizes Clonal Selection from Receptor Selection

TL;DR: It is shown here that sensitivity to antigen-induced apoptosis arises relatively late in B cell development and is preceded by a functionally distinct developmental stage capable of receptor editing, which compartmentalizes clonal selection from receptor selection.
Journal ArticleDOI

Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells

TL;DR: Human Breg cells decrease the proliferation of CD4(+) T cells and also enhance the expression of Foxp3 and CTLA-4 in Treg cells by cell-to-cell contact.
Journal ArticleDOI

Distinct Signal Thresholds for the Unique Antigen Receptor–Linked Gene Expression Programs in Mature and Immature B Cells

TL;DR: It is demonstrated that signaling by B cell antigen receptors leads to distinct and mutually exclusive biologic responses in mature and immature B cells: upregulation of CD86, CD69, and MHC class II in mature cells and receptor editing in immature cells.
Journal ArticleDOI

B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging

TL;DR: The results suggest that immunosenescence in the B-lineage is not irreversible and that depletion of the long-lived B cells in old mice rejuvenates the B -lineage and enhances immune competence.